The European Commission has granted orphan drug designation to ILB, Tikomed‘s investigational treatment for amyotrophic…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Measurements taken of muscle using ultrasound could be useful in diagnosing or managing amyotrophic lateral sclerosis (ALS), a small study…
Bereaved caregivers of people with motor neurone disease (MND) are at increased risk of prolonged grief disorder compared to the…
Long delays between symptom onset and diagnosis are common with amyotrophic lateral sclerosis (ALS), and need not be if …
Barriers need to be overcome in order to facilitate community engagement programs for people with motor neurone disease (MND),…
A research project underway at the University of Rhode Island (URI) aims to help people with advanced amyotrophic…
The COVID-19 pandemic has imposed new challenges on diagnosing, monitoring, and caring for people with amyotrophic lateral sclerosis…
For people with amyotrophic lateral sclerosis (ALS) currently on non-invasive ventilation, modifications to existing equipment may help to minimize…
Changes in the metabolism of a class of fat molecules called sphingolipids may be a cause of motor neuron diseases…
The Muscular Dystrophy Association (MDA) is hosting an online Q&A session today to discuss the best ways that people…